sGP Serves as a Structural Protein in Ebola Virus Infection

被引:17
|
作者
Iwasa, Ayaka
Shimojima, Masayuki [3 ]
Kawaoka, Yoshihiro [1 ,2 ,4 ,5 ]
机构
[1] Univ Tokyo, Dept Microbiol & Immunol, Inst Med Sci, Div Virol,Minato Ku, Tokyo 1088639, Japan
[2] Univ Tokyo, Int Res Ctr Infect Dis, Inst Med Sci, Tokyo 1088639, Japan
[3] Yamaguchi Univ, Fac Agr, Lab Vet Microbiol, Saitama, Japan
[4] Japan Sci & Technol Agcy, ERATO Infect Induced Host Responses Project, Saitama, Japan
[5] Univ Wisconsin, Sch Vet Med, Dept Pathobiol Sci, Madison, WI 53706 USA
来源
关键词
SMALL GLYCOPROTEIN SGP; VIRION GLYCOPROTEINS; DISTINCT MECHANISMS; ANTIBODY; BINDING; ENTRY; IDENTIFICATION; RESIDUES; RECEPTOR; CYTOTOXICITY;
D O I
10.1093/infdis/jir313
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Methods. We expressed ZEBOV GP(1,2), VP40, and NP proteins, together with sGP protein, from expression plasmids and examined the resultant virus-like particles by using Western blot. Cells expressing GP(2) in combination with either GP(1) or sGP were analyzed by using flow cytometry with the KZ52 antibody, which recognizes a GP(1,2) conformational epitope. A VSV pseudotype, VSV delta G*, which expresses a GFP reporter gene instead of the G protein, was used to produce pseudotyped viruses encoding sGP and variants of GP to test the contribution of sGP to infectivity. Results. Western blot and flow cytometric analyses suggested the existence of a covalently linked sGP-GP(2) molecule. VSV delta G*(sGP + GP(2)) and VSV delta G*(GP(1,2)) infected Vero E6 cells and were neutralized by the KZ52 antibody. Overexpression of sGP reduced the titer of VSV delta G*(GP(1,2)). Conclusions. ZEBOV sGP can substitute for GP(1), forming a sGP-GP(2) complex and conferring infectivity. Our studies suggest a novel role for sGP as a structural protein.
引用
收藏
页码:S897 / S903
页数:7
相关论文
共 50 条
  • [21] The nonstructural small glycoprotein sGP of ebola virus is secreted as an antiparallel-orientated homodimer
    Volchkova, VA
    Feldmann, H
    Klenk, HD
    Volchkov, VE
    VIROLOGY, 1998, 250 (02) : 408 - 414
  • [22] Immune Response to Ebola Virus Infection
    Alonso Remedios, Alain
    Perez Cutino, Maite
    Pardo Martinez, Daynelis
    Piloto Orraca, Yasmina
    Ojeda Martinez, Blayser
    Casenave-Cambet Ramirez, Randy
    MEDISUR-REVISTA DE CIENCIAS MEDICAS DE CIENFUEGOS, 2016, 14 (03): : 313 - 319
  • [23] Immune barriers of Ebola virus infection
    McElroy, Anita K.
    Muhlberger, Elke
    Munoz-Fontela, Cesar
    CURRENT OPINION IN VIROLOGY, 2018, 28 : 152 - 160
  • [24] Neurological Complications of Ebola Virus Infection
    Bridgette Jeanne Billioux
    Bryan Smith
    Avindra Nath
    Neurotherapeutics, 2016, 13 : 461 - 470
  • [25] Malaria Therapy for Ebola Virus Infection
    Drancourt, Michel
    Raoult, Didier
    CLINICAL INFECTIOUS DISEASES, 2017, 64 (05) : 696 - 697
  • [26] Neurological Complications of Ebola Virus Infection
    Billioux, Bridgette Jeanne
    Smith, Bryan
    Nath, Avindra
    NEUROTHERAPEUTICS, 2016, 13 (03) : 461 - 470
  • [27] Vaccine for AIDS and Ebola virus infection
    Nabel, GJ
    VIRUS RESEARCH, 2003, 92 (02) : 213 - 217
  • [28] Adipocytes are susceptible to Ebola Virus infection
    Gourronc, Francoise A.
    Rebagliati, Michael R.
    Kramer-Riesberg, Breanna
    Fleck, Anthony M.
    Patten, J. J.
    Geohegan-Barek, Kathleen
    Messingham, Kelly N.
    Davey, Robert A.
    Maury, Wendy
    Klingelhutz, Aloysius J.
    VIROLOGY, 2022, 573 : 12 - 22
  • [29] Ebola virus as a sexually transmitted infection
    Rogstad, Karen E.
    Tunbridge, Anne
    CURRENT OPINION IN INFECTIOUS DISEASES, 2015, 28 (01) : 83 - 85
  • [30] CASE OF EBOLA VIRUS-INFECTION
    EMOND, RTD
    EVANS, B
    BOWEN, ETW
    LLOYD, G
    BMJ-BRITISH MEDICAL JOURNAL, 1977, 2 (6086): : 541 - 544